Prognostic relevance of CD105-assessed microvessel density in laryngeal carcinoma

Otolaryngology - Head and Neck Surgery

Volumn 141, Issue 4, 2009, Pages 478-483

  Zvrko, Elvir ^a   Mikic, Anton ^b   Vuckovic, Ljiljana ^a   Djukic, Vojko ^b   Knezevic, Milan ^c  

^a UNIVERSITY OF MONTENEGRO   (Montenegro)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c UNIVERSITY OF KRAGUJEVAC   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ENDOGLIN; ENDOGLIN ANTIBODY; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DENSITY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROVESSEL DENSITY; OUTCOME ASSESSMENT; PROGNOSIS; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; MALE; MICROVESSELS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RECEPTORS, CELL SURFACE; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 70349484441     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2009.07.001     Document Type: Article

References (23)

1. Folkman J., Watson K., Ingiber D., et al. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature (Lond) 339 (1989) 58-61
2. Folkman J. Angiogenesis and breast cancer. J Clin Oncol 12 (1994) 441-443
3. Minhajat R., Mori D., Yamasaki F., et al. Organ-specific endoglin (CD105) expression in the angiogenesis of human cancers. Pathol Int 56 (2006) 717-723
4. Li S.L., Gao D.L., Zhao Z.H., et al. Correlation of matrix metalloproteinase suppressor genes RECK, VEGF, and CD105 with angiogenesis and biological behavior in esophageal squamous cell carcinoma. World J Gastroenterol 13 (2007) 6076-6081
5. Saad R.S., Liu Y.L., Nathan G., et al. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer. Mod Pathol 17 (2004) 197-203
6. Kumar S., Ghellal A., Li C., et al. Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis. Cancer Res 59 (1999) 856-861
7. Massi D., Franchi A., Paglierani M., et al. Vasculogenic mimicry has no prognostic significance in pT3 and pT4 cutaneous melanoma. Hum Pathol 35 (2004) 496-502
8. Tanaka F., Otake Y., Yanagihara K., et al. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody. Clinical Cancer Res 7 (2001) 3410-3415
9. Salvesen H.B., Gulluoglu M.G., Stefansson I., et al. Significance of CD 105 expression for tumour angiogenesis and prognosis in endometrial carcinomas. APMIS 111 (2003) 1011-1018
10. Wilkstrom P., Lissbrant I.F., Stattin P., et al. Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer. Prostate 51 (2002) 268-275
11. Yagasaki H., Kawata N., Takimoto Y., et al. Histopathological analysis of angiogenic factors in renal cell carcinoma. Int J Urol 10 (2003) 220-227
12. Martone T., Rosso P., Albera R., et al. Prognostic relevance of CD105+ microvessel density in HNSCC patient outcome. Oral Oncol 41 (2005) 147-155
13. Pruneri G., Ponzoni M., Ferreri A.J., et al. Microvessel density, a surrogate marker of angiogenesis, is significantly related to survival in multiple myeloma patients. Br J Haematol 118 (2002) 817-820
14. Pruneri G., Bertolini F., Baldini L., et al. Angiogenesis occurs in hairy cell leukaemia (HCL) and in NOD/SCID mice transplanted with the HCL line bonna-12. Br J Haematol 120 (2003) 695-698
15. Weidner N., Semple J.P., Welch W.R., et al. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324 (1991) 1-8
16. Schimming R., and Marme D. Endoglin (CD105) expression in squamous cell carcinoma of the oral cavity. Head Neck 24 (2002) 151-156
17. Kyzas P.A., Agnantis N.J., and Stefanou D. Endoglin (CD105) as a prognostic factor in head and neck squamous cell carcinoma. Virchows Arch 448 (2006) 768-775
18. Marioni G., Ottaviano G., Giacomelli L., et al. CD105-assessed micro-vessel density is associated with malignancy recurrence in laryngeal squamous cell carcinoma. Eur J Surg Oncol 32 (2006) 1149-1153
19. Gu X., Xu Y., Wu H., et al. Relationship between CD105 and angiogenesis and biological behaviors in squamous carcinoma of larynx [Chinese]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 20 (2006) 125-128
20. Marioni G., D'Alessandro E., Giacomelli L., et al. Maspin nuclear localization is related to reduced density of tumour-associated micro-vessels in laryngeal carcinoma. Anticancer Res 26 (2006) 4927-4932
21. Li Q., Zhang B., and Peng P. Relevance of endoglin (CD105) VEGF and p53 with invasion metastasis and prognosis of laryngeal carcinoma [Chinese]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 21 (2007) 1114-1117
22. Liu Y., Xue X., and Wang F. The expressions of TP, MK and CD105 in laryngeal squamous cell carcinoma and their clinical significance [Chinese]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 22 (2008) 100-103
23. Marioni G., Giacomelli L., D'Alessandro E., et al. Laryngeal carcinoma recurrence rate and disease-free interval are related to CD105 expression but not to vascular endothelial growth factor 2 (Flk-1/Kdr) expression. Anticancer Res 28 (2008) 551-557